SciHub
文献互助
期刊查询
一搜即达
科研导航
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
自由的水云
Lv4
430 积分
2024-05-08 加入
最近求助
最近应助
互助留言
Achievable but elusive: LLDAS and DORIS remission in clinical trials of belimumab
1小时前
求助中
AML treatment: conventional chemotherapy and emerging novel agents
4天前
已完结
BCMA-Targeted T-Cell–Engager Therapy for Autoimmune Disease
7天前
已完结
Camrelizumab plus rivoceranib versus sorafenib as first-line therapy for unresectable hepatocellular carcinoma (CARES-310): a randomised, open-label, international phase 3 study
13天前
已完结
Antigen escape as a shared mechanism of resistance to BCMA-directed therapies in multiple myeloma
22天前
已完结
Evaluation of in vitro/in vivo bystander effect and immunogenic cell death induction by MORAb-202 (farletuzumab ecteribulin)
24天前
已完结
Claudin 18.2 as a novel therapeutic target
30天前
已完结
Neurocognitive and hypokinetic movement disorder with features of parkinsonism after BCMA-targeting CAR-T cell therapy
1个月前
已完结
A DXd/TLR7-agonist dual-conjugate anti-HER2 ADC exerts robust anti-tumor activity through tumor cell killing and immune activation
1个月前
已完结
Development of Peptide Paratope Mimics Derived from the Anti-ROR1 Antibody and Long-Acting Peptide–Drug Conjugates for Targeted Cancer Therapy
1个月前
已完结
没有进行任何应助
没有进行任何互助留言
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论